Press Release

Rising Number of People with Heart Valve Diseases Anticipated to Fuel the Growth of the Global Heart Valve Devices market

The rising geriatric population, rise number of people suffering from heart valve diseases, and snowballing government investment for heart valve research are some of the factors propelling the growth of the global heart valve devices market. Besides these, extensive government investment for heart valve research, rising expenditure on healthcare infrastructure coupled with the escalating number of valve replacement and repair procedures, and growing strategic partnerships by the key market players are anticipated to strongly contribute toward the growth of the market in the forecast period.

According to MarkNtel Advisors’ research report titled “Global Heart Valve Devices Market Analysis, 2020”, the Global Heart Valve Devices market is anticipated to grow at a CAGR of around 14% during 2020-25. Based on End User, Hospitals acquired a considerable market share in 2019. The growth of the segment is attributed to the growing availability of various modern procedures such as transcatheter-based, MI robotic-assisted procedures in the hospitals for treating heart-valve diseases, and increasing investment by the government toward the advancement of healthcare infrastructure in the developed and developing countries.

“Global Heart Valve Devices Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Heart Valve Devices providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.

North America Dominated the Market

North America dominated the Global Heart Valve Device market in 2019. The US acquired the majority market share in the share of the North America segment. This is due to a high rate of obesity, rising prevalence of cardiac diseases, and surging government funding toward the development of healthcare infrastructure. Besides these, increase in funding in R&D activities, presence of major market players, a growing elderly population, increase in the risk of heart valve diseases, and advancement in heart surgical procedure are key factors expected to promote the growth of the Heart Valve Devices Market in the forthcoming period as stated in MarkNtel Advisors’ research report “Global Heart Valve Devices Market Analysis, 2020”. 

According to MarkNtel Advisors, the key players with a considerable market share in the Global Heart Valve Devices market are JenaValve Technology, Inc., Xeltis, TTK Healthcare, Boston Scientific Corporation, Edward Lifesciences Corporation, Abbott Laboratories, Lepu Medical Technology (Beijing) Co., Ltd., Novostia SA, Medtronic Plc, Neovasc, Inc., Micro Interventional Devices, LivaNova PLC, Venus Medtech, Meril Life Sciences Pvt. Ltd., On-X Life Technologies, Inc.  etc.

Market Segmentation:

1. By Product (Mechanical Valves [Mitral Valves, Aortic Valves], Tissue/Bio-Prosthetic Valves [Mitral Valves, Aortic Valves, Pulmonary Valves, Tricuspid Valves], Transcatheter Valves [Mitral Valves, Aortic Valves, Pulmonary Valves])
2. By Procedure (Heart Valve Repair Devices, Heart Valve Replacement Devices)
3. By End-User (Hospitals, Specialty Centers, Ambulatory Surgical Centers)
4. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
5. By Country (US, Canada, Mexico, Brazil, Argentina, UK, Germany, France, Spain, Italy, China, Japan, India, South East Asia, Australia, UAE, Saudi Arabia, South Africa),
6. By Company (JenaValve Technology, Inc., Xeltis, TTK Healthcare, Boston Scientific Corporation, Edward Lifesciences Corporation, Abbott Laboratories, Lepu Medical Technology (Beijing) Co., Ltd., Novostia SA, Medtronic Plc, Neovasc, Inc., Micro Interventional Devices, LivaNova PLC, Venus Medtech, Meril Life Sciences Pvt. Ltd., On-X Life Technologies, Inc., etc.)

Key questions answered in the study:

1. What are the current and future trends of the Heart Valve Devices industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Heart Valve Devices industry?
5. What are the customer orientation, purchase behavior, and expectations from the Heart Valve Devices firms across various regions?